Recurrent Breast Cancer Completed Phase 0 Trials for Cabergoline (DB00248)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01730729Cabergoline in Metastatic Breast CancerTreatment